Nora Be
Product Images NDC 52544-629

3 FDA label images from Actavis Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nora Be (NDC 52544-629). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Norethindrone Structural Formula. (Nora Be 1)

Norethindrone Structural Formula. (Nora Be 1)
Chemical structure diagram of an active ingredient, showing a steroid-like molecular framework with hydroxyl, methyl, and alkynyl functional groups, consistent with hormone-based compounds seen in Nora BE products by Actavis Pharma, Inc.*
FDA Label Image

Figure 1: Mean ± Sd Norethindrone Plasma Concentrations Following Nora-be Administration. (Nora Be 2)

Figure 1: Mean ± Sd Norethindrone Plasma Concentrations Following Nora-be Administration. (Nora Be 2)
A line graph titled 'Mean ± SD Norethindrone Plasma Concentrations Following Nora-BE Administration' showing plasma concentration (pg/mL) on the y-axis and time (hours) on the x-axis. The graph presents concentration decline over 48 hours after a 0.35 mg oral dose of Nora BE, with data points connected by a line and error bars representing standard deviation.*
FDA Label Image

For Current Package And Further Product Information, Please Visit Www.watson.com Or Www.oralcontraceptives.com Or Call Our Medical Communications Department Toll-free At 1-800-272-5525. (Nora Be 3)

For Current Package And Further Product Information, Please Visit Www.watson.com Or Www.oralcontraceptives.com Or Call Our Medical Communications Department Toll-free At 1-800-272-5525. (Nora Be 3)
Nora BE 0.35 mg tablets label panel from Actavis Pharma, Inc. The label indicates the active ingredient as Norethindrone, with 0.35 mg strength, presented as tablets USP. The packaging states it contains 6 tablet dispensers with 28 tablets each and includes prescribing notes and storage instructions. The label is primarily yellow with blue and black text and the Actavis logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.